Table 2 Association results from the exome sequencing, targeted sequencing, replication and combined analyses by using logistic regression (additive model).

From: Sequencing-based approach identified three new susceptibility loci for psoriasis

Chr

Gene of interest

Variant ID

Stage*

Allele

MAF

P -value

OR (95% CI)

Combined

     

Cases

Controls

  

P -value

OR (95% CI)

12p13.3

Multiple genes

rs758739

i

G/C

0.2662

0.2957

2.08 × 10−1

0.86 (0.72–1.04)

4.08 × 10−8

0.91 (0.89–0.97)

   

ii

G/C

0.2681

0.2822

1.72 × 10−3

0.93 (0.89–0.97)

  
   

iii

G/C

0.2642

0.2911

4.51 × 10−6

0.87 (0.83–0.93)

  

12p13.3

Multiple genes

rs2243750

i

C/T

0.3026

0.3229

2.48 × 10−1

0.91 (0.76–1.05)

4.38 × 10−8

0.91 (0.89–0.97)

   

ii

C/T

0.3265

0.3436

4.70 × 10−4

0.93 (0.89–0.97)

  
   

iii

C/T

0.3056

0.3308

3.49 × 10−5

0.89 (0.84–0.94)

  

17q12

IKZF3

rs10852936

i

T/C

0.2795

0.2563

2.42 × 10−1

1.13 (0.88–1.25)

1.96 × 10−8

1.10 (1.05–1.15)

   

ii

T/C

0.2972

0.2778

2.31 × 10−5

1.10 (1.05–1.15)

  
   

iii

T/C

0.2939

0.2722

2.26 × 10−4

1.11 (1.05–1.18)

  

17q12

IKZF3

rs12936231

i

G/C

0.3019

0.2537

4.07 × 10−1

1.27 (1.11–1.96)

5.02 × 10−8

1.10 (1.04–1.17)

   

ii

G/C

0.3015

0.2837

9.24 × 10−5

1.09 (1.04–1.14)

  
   

iii

G/C

0.2928

0.2726

6.87 × 10−4

1.11 (1.04–1.17)

  

20q13.2

RNF114

rs4647954

i

C/T

0.4234

0.4021

2.49 × 10−1

1.09 (0.94–1.27)

2.41 × 10−7

1.09 (1.05–1.14)

   

ii

C/T

0.4316

0.4105

2.27 × 10−5

1.09 (1.05–1.14)

  
   

iii

C/T

0.4267

0.4086

6.04 × 10−3

1.08 (1.02–1.14)

  

3p21.31

CDCP1

rs1863837

i

C/T

0.2412

0.2494

6.82 × 10−1

0.96 (0.74–1.09)

3.91 × 10−7

0.90 (0.86–0.95)

   

ii

C/T

0.2240

0.2414

8.87 × 10−5

0.91 (0.86–0.95)

  
   

iii

C/T

0.2144

0.2356

2.06 × 10−3

0.89 (0.82–0.96)

  

17q25

TRIM47

rs3744017

i

A/G

0.1837

0.1490

1.34 × 10−2

1.26 (1.05–1.56)

5.83 × 10−7

1.12 (1.05–1.17)

   

ii

A/G

0.1595

0.1462

2.70 × 10−4

1.11 (1.05–1.17)

  
   

iii

A/G

0.1656

0.1522

5.70 × 10−3

1.11 (1.03–1.19)

  
  1. CI, confidence interval; MAF, mutation annotation format; OR, odds ratio.
  2. *Stage i: exome sequencing in 1,457 individuals; stage ii: targeted sequencing in 19,852 individuals; stage iii: genotyping in 11,001 individuals.